Authors:
HERTOGS K
DEBETHUNE MP
MILLER V
IVENS T
SCHEL P
VANCAUWENBERGE A
VANDENEYNDE C
VANGERWEN V
AZIJN H
VANHOUTTE M
PEETERS F
STASZEWSKI S
CONANT M
BLOOR S
KEMP S
LARDER B
PAUWELS R
Citation: K. Hertogs et al., A RAPID METHOD FOR SIMULTANEOUS DETECTION OF PHENOTYPIC RESISTANCE TOINHIBITORS OF PROTEASE AND REVERSE-TRANSCRIPTASE IN RECOMBINANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES FROM PATIENTS TREATED WITH ANTIRETROVIRAL DRUGS, Antimicrobial agents and chemotherapy, 42(2), 1998, pp. 269-276
Authors:
BRUISTEN SM
FRISSEN PHJ
VANSWIETEN P
HARRIGAN PR
KINGHORN I
LARDER B
WEIGEL HM
DEVRIES E
REGEZ RM
HENRICHS JH
KOOT M
HUISMAN JG
Citation: Sm. Bruisten et al., PROSPECTIVE LONGITUDINAL ANALYSIS OF VIRAL LOAD AND SURROGATE MARKERSIN RELATION TO CLINICAL PROGRESSION IN HIV TYPE 1-INFECTED PERSONS, AIDS research and human retroviruses, 13(4), 1997, pp. 327-335
Citation: B. Larder et C. Boucher, 4TH INTERNATIONAL WORKSHOP - ABSTRACTS PRESENTED AT A WORKSHOP HELD IN SARDINIA, ITALY ON JULY 6-9, 1995 - INTRODUCTION, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 11-11
Citation: C. Boucher et B. Larder, HIV VARIATION - CONSEQUENCES FOR ANTIVIRAL THERAPY AND DISEASE PROGRESSION, Reviews in medical virology, 5(1), 1995, pp. 7-21
Authors:
CALDERON EJ
TORRES Y
MEDRANO FJ
LUQUE F
LARDER B
REY C
SANCHEZOUIJANO A
LISSEN E
LEAL M
Citation: Ej. Calderon et al., EMERGENCE AND CLINICAL RELEVANCE OF MUTATIONS ASSOCIATED WITH ZIDOVUDINE RESISTANCE IN ASYMPTOMATIC HIV-1-INFECTED PATIENTS, European journal of clinical microbiology & infectious diseases, 14(6), 1995, pp. 512-519
Authors:
MEIER UC
KLENERMANN P
MCADAM S
KOEPPE B
JONES SR
MCMICHAEL A
LARDER B
PHILLIPS R
Citation: Uc. Meier et al., HIV REVERSE-TRANSCRIPTASE MUTATION ENABLES EVASION OF CTL MEDIATED IMMUNITY, Journal of cellular biochemistry, 1995, pp. 222-222
Authors:
LUQUE F
CARUZ A
PINEDA JA
TORRES Y
LARDER B
LEAL M
Citation: F. Luque et al., PROVIRUS LOAD CHANGES IN UNTREATED AND ZIDOVUDINE-TREATED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PATIENTS, The Journal of infectious diseases, 169(2), 1994, pp. 267-273